ZTS · 10-Q · 2026Q2 · Full report

Operating Expense Trends

Zoetis Inc. · 2026-08-06 · Importance 31 · Surprise 32 · No source text

Six-month SG&A expense decreased 1%, or $8 million, primarily because of lower depreciation, lower certain significant items and lower charitable contributions. Six-month R&D expense increased 8%, or $25 million, due to higher project investments, compensation costs supporting innovation and portfolio progression, and unfavorable foreign exchange. In the second quarter, SG&A declined 4%, or $22 million, while R&D increased 4%, or $7 million.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
operating_incomepositiverealized+0.9%SG&A expenses decreased by $22 million, or 4%, in the three months ended June 30, 2026 compared with the three months ended June 30, 2025,…
operating_incomepositiverealized+0.3%SG&A expenses decreased by $8 million, or 1%, in the six months ended June 30, 2026 compared with the six months ended June 30, 2025,…
operating_incomenegativerealizedSelling, general and administrative expenses were $1,180 million for the six months ended June 30, 2026.